Medication info

NPIS Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletSucralfate Hydrate›300mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tablet
Manufacturer / importer
Alpha Pharmaceutical Co., Ltd.
Appearance
Green, round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 201902358 · Approved 2019.04.17

This product's status changed to Expired on 2024.04.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastric and esophageal disorders (including ulcers) and Zollinger-Ellison syndrome; prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
○ Adults Usually, 2 tablets are administered orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same when used in combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may sometimes take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment at a dose of 2 tablets 3 times daily and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Alpha Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastric and esophageal disorders (including ulcers) and Zollinger-Ellison syndrome; prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
View approved original text

This medication is used to treat ulcers that occur in the stomach and duodenum. It is also effective for specific conditions such as gastritis and Zollinger-Ellison syndrome. It helps relieve symptoms due to gastroesophageal reflux disease and is administered to prevent Mendelson's syndrome during the preoperative anesthesia process. It is also used to improve symptoms and aid healing in gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs).

How to take

Adult dose

○ Adults Usually, 2 tablets are administered orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same when used in combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may sometimes take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment at a dose of 2 tablets 3 times daily and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients with poor kidney function or those undergoing dialysis. Additionally, it should be avoided in patients who have had an allergy to this drug or its components, those with a history of acute porphyria, patients who have undergone upper gastrointestinal surgery, pregnant women or women who may become pregnant, premature infants and neonates, and those on a potassium-restricted diet. Patients with liver dysfunction, those with a history of drug allergy, the elderly, patients with kidney issues, and those using nonsteroidal anti-inflammatory drugs should be closely monitored when using this medication. It is important to verify malignancy in patients with gastric ulcers or those over middle age who have newly developed or changed dyspeptic symptoms, as this medication can mask symptoms of gastric cancer. Patients with gastric or duodenal ulcers harboring Helicobacter pylori require additional treatment to eradicate the bacteria. Caution is advised for patients in intensive care or those with hypophosphatemia, and for those who have difficulty swallowing. While taking this medication, various side effects such as allergic reactions, shock, skin rashes, urticaria, blood abnormalities, liver dysfunction, cardiac arrhythmia, digestive disorders, neurological symptoms, myalgia, hair loss, etc., may occur, and any unusual symptoms should prompt immediate consultation with medical staff. Long-term continuous use is not recommended, and if therapeutic efficacy is absent, switching to another medication is advisable. The elderly, patients with chronic pulmonary disease, diabetes, or weakened immune systems are at higher risk for pneumonia, hence caution is warranted. If dizziness or drowsiness occurs, avoid driving or operating hazardous machinery. This medication may interact with other drugs, so inform the healthcare provider of any medications being taken, especially when used with anticoagulants or antibiotics. It is safest for pregnant or breastfeeding women not to use this medication. The safety and efficacy of this drug have not been sufficiently established in children, hence its use is not recommended. In case of overdose, emergency measures such as vomiting or gastric lavage may be necessary, and in severe cases, removal via hemodialysis can be performed. This medication reduces gastric acid secretion, which may promote bacterial growth in the gastrointestinal tract, so an eye examination may be necessary with long-term use.

Side effects

  • anaphylactic shock
  • skin rash
  • hives
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • neutropenia
  • leukopenia
Show 50 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous and mucosal bleeding
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • feeling of heaviness in the head
  • disease sensation
  • anxiety
  • mental disorientation
  • depression
  • hallucination
  • blurred vision
  • involuntary movement disorders
  • consciousness disturbance
  • hypertrophic muscle cramps
  • gynecomastia
  • excessive lactation
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • darkening of the tongue
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air ingress, and it is recommended to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage can maintain the medication's efficacy and prevent deterioration.

Appearance and packaging

Appearance

Green, round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.